This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. slipped 3.2% to $150.52 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.6% to 5,611.85 and the Dow Jones Industrial Average rising 1.0% to 42,001.76.
This was the stock's sixth consecutive day of losses.
Charles River Laboratories International Inc. closed 44.9% below its 52-week high of $273.32, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors, as Labcorp Holdings Inc. rose 1.2% to $232.74, Alnylam Pharmaceuticals Inc. rose 0.6% to $270.02, and Bio-Techne Corp. fell 0.17% to $58.63.
Trading volume totaled 1.4 million, compared to the 50-day average of 1.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 31, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。